chimerization at the aqp2–aqp3 locus is the genetic basis of melarsoprol–pentamidine cross-resistance in clinical trypanosoma brucei gambiense isolates
Clicks: 182
ID: 147591
2015
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
0.9
/100
3 views
3 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Aquaglyceroporin-2 is a known determinant of melarsoprol–pentamidine cross-resistance in Trypanosoma brucei brucei laboratory strains. Recently, chimerization at the AQP2–AQP3 tandem locus was described from melarsoprol–pentamidine cross-resistant Trypanosoma brucei gambiense isolates from sleeping sickness patients in the Democratic Republic of the Congo. Here, we demonstrate that reintroduction of wild-type AQP2 into one of these isolates fully restores drug susceptibility while expression of the chimeric AQP2/3 gene in aqp2–aqp3 null T. b. brucei does not. This proves that AQP2–AQP3 chimerization is the cause of melarsoprol–pentamidine cross-resistance in the T. b. gambiense isolates.Reference Key |
graf2015internationalchimerization
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
---|---|
Authors | ;Fabrice E. Graf;Nicola Baker;Jane C. Munday;Harry P. de Koning;David Horn;Pascal Mäser |
Journal | deutsche zeitschrift fur philosophie |
Year | 2015 |
DOI | 10.1016/j.ijpddr.2015.04.002 |
URL | |
Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.